Daily filing brief

10 Important BSE and NSE Announcements — 8 August 2026

Daily Briefer presents 10 important BSE and NSE announcements for 8 August 2026, selected for their relevance and potential impact on listed companies and shareholders. Each concise summary is linked to the original exchange filing so readers can verify the full context.

  1. Krishna Institute of Medical Sciences Ltd10:50 pm IST

    KIMS Hospitals Q1 FY27: revenue 1,180 crore; debt reduced; Kondapur ramp-up and empanelment progress.

    Financial Performance

    • Quarter 1 FY27 consolidated revenue 1,180 crore, up 35.3% YoY.
    • Quarter 1 FY27 EBITDA pre-Ind AS 222 crore, up 14.6% YoY.
    • EBITDA margin 20.1% in Q1 FY27; 20.27% Q1 FY26; 19.9% Q4 FY26.
    • PAT INR 37 crore in Q1 FY27; Q1 FY26 INR 85 crore; Q4 FY26 INR 33 crore.
    • Cash and equivalents INR 505 crore as of 30 Jun 2026.
    • QIP raised INR 1,500 crore; INR 1,100 crore utilized to reduce debt.
    • Promoter preferential allotment INR 600 crore; 25% upfront; balance in 18 months.
    • Debt reduced from INR 3,250 crore (Mar 31, 2026) to around INR 2,400 crore by early July.
    • Kondapur hospital commissioned; first patient admitted June 20; July revenue grew 40%.

    Growth and Capex

    • Palakkad Kerala unit opened; Bengaluru Mahadevapura break-even achieved.
    • Electronic City expected break-even in 1-2 quarters.
    • CAPEX last quarter ~INR 60-75 crore; Rajahmundry capex ~60-75 crore this year.
    • Next nine months CAPEX ~INR 100-125 crore across three assets; Kondapur largely done.
    • O&M agreements with Golden Lane and Sarvottam; 300-bed near Kondapur; revenue potential INR 90-95 crore/month.
    • Empanelment progress: 50% of insurers empanelled; remaining 50% pursued; most by Aug-Sep.
    • Debt-equity target 2.5:1; internal accruals for growth CAPEX.

    Operations and Margin Trajectory

    • Telangana occupancy around 50-52%; Kondapur beds added late; 70% ramp target in 3-4 years.
    • Nashik break-even; Thane margins around 10% in June; improvement expected.
    • Mahadevapura break-even achieved; Electronic City expected break-even by year-end or 1-2 quarters.
    • Bengaluru ARPOB around INR 80,000–85,000; ARPP similar; empanelments will normalize.
    • Kerala margins targeted at 20–22% over 2-3 years; current single-digit.
    • ARPOB growth guidance: 4–5% sustainable; management cautions progress.

    Outlook and Q&A Highlights

    • No formal FY27 guidance yet; focus on stabilizing current hospitals.
    • Kondapur revenue potential around INR 1,200 crore annually (~INR 100 crore/month).
    • Other expansion plans depend on empanelments; potential greenfield/brownfield in core markets.
    • Old Kondapur rentals ~INR 90 lakhs/month; annual ~INR 12 crore; additional costs ~INR 3–4 crore.
    • O&M deals yield top-line share; P&L impact material only after ramp-up.
    • Common empanelment progress; industry updates expected in coming months.
    Read the original filing
  2. Unimech Aerospace and Manufacturing Ltd4:00 pm IST

    Unimech Aerospace Q1 FY27: Revenue at INR108 crore; Hobel Bellows integration; nuclear orders INR87 crore; capex and QIP plans underway

    Financial Performance

    • Q1 FY27 revenue approximately INR108 crores; 32% sequential growth over Q4 FY26; 71% YoY.
    • Hobel Bellows revenue contributed in two months; total ~INR22 crores.
    • Aero tooling ~76% of revenue; Hobel Bellows ~21%.
    • Gross margin 65%; EBITDA margin approximately 36.5%.
    • PAT around INR28 crores; PAT margin 24%; 46% YoY growth; 7% QoQ.
    • Other income ~INR7 crores; lower than prior quarter due to treasury funds deployed to Hobel Bellows.

    Order Book and Pipeline

    • Consolidated order book including Hobel ~INR280 crores as of 30 June 2026.
    • Nuclear orders INR87 crores; execution planned during the second half of the financial year.
    • FACC Austria long-term supply agreement is USD7.5 million over five years.
    • Hobel Bellows integration progressing; cross-selling to other industries; two new locomotive and power-gen customers onboarding by year-end subject to qualification.

    Capex and Projects

    • No significant core capex planned in FY27; capacity expansion tied to qualification programs.
    • Saudi Arabia JV with Kanoo Group: capex to proceed; gross block by FY27 ~ double; US$10 million infusion into JV this month.
    • AS9100 certification for Vizag facility targeted by Q4 FY27.
    • Free trade warehousing zone fully operational.

    Operational Metrics

    • Utilization ~58%; ~10% of capacity committed to qualification and new product introductions.
    • Working capital days ~130; could rise toward ~160 days by year-end.
    • Finance cost ~INR2 crores; depreciation ~INR8 crores; headcount ~1,232.

    Guidance and Outlook

    • FY27 outlook: expect meaningful consolidated growth; next quarter stronger with higher revenue and robust EBITDA margins.
    • Consolidated gross margin around 65% sustainable; blended EBITDA margin target of 30-32% plus; near-term 34-35% possible.
    • Nuclear and tooling demand pipeline remains strong; more opportunities visible in nuclear tenders.

    Fundraising and Strategic Initiatives

    • Board-approved fundraising up to INR750 crores via QIP to meet minimum public shareholding and capture demand tailwinds.
    • Inorganic growth potential; M&A considered to build capacity as needed.
    • Dheya Engineering Technologies: Unimech to participate in USD10 million equity raise; exclusive manufacturing arrangement unchanged; possible modest dilution.
    • Saudi Kanoo JV expands international manufacturing footprint; localization opportunities in Saudi Arabia.

    Q&A Highlights

    • Nuclear order execution timeline: INR87 crores to be executed in H2 FY27; remaining opportunities later.
    • Hobel contribution: ~INR22 crores revenue in two months; consolidated EBITDA margin 36.5%.
    • Gross margin guidance: around 65% sustainable; FY27 margins around 34-35%.
    • Asset turns and ROCE: current asset turn ~2x; potential 2.5x–3x; ROCE ~20–21% with higher utilization.
    • Leap engine talks confidential; MRO expansion contemplated when opportunities arise.
    • Tooling vs PCA mix: tooling dominates aero engine components; PCA growing with direct OEM engagements.
    Read the original filing
  3. C.E. Info Systems Ltd7:56 pm IST

    MapmyIndia Q1 FY27: Revenue up 14.9% to INR 139.7 crores; EBITDA 40.2% margin; one-time write-off; open order book ~INR 1,750 crores; full-year EBITDA target 35%+.

    Financial performance

    • Q1 FY27 revenue rose 14.9% YoY to INR 139.7 crores; EBITDA INR 56.1 crores (40.2%).
    • PAT rose 8.6% to INR 49.7 crores; PAT margin 31.2%.

    Segment mix

    • Consolidated Q1 revenue split: Map-led INR 98.7 crores; IoT-led INR 41.0 crores.
    • Open order book end-FY26 stood at INR 1,750 crores, up from INR 1,500 crores.

    One-offs and margins

    • One-time government client write-off of INR 4 crores; net P&L impact INR 0.8 crores.
    • EBITDA margin was impacted about 4 percentage points in the quarter.

    Receivables and government exposure

    • FY26 end receivables were about INR 176 crores; government exposure was the majority.
    • Q1 balance sheet details were not disclosed on the call.

    Guidance and outlook

    • Management targets full-year EBITDA margin of 35%+; quarterly margins may vary.

    Strategic direction and international

    • AI-led push; multi-product, multi-industry MAP-led and IoT-led offerings.
    • International expansion ongoing but not material to current P&L.
    Read the original filing
  4. Aditya Birla Fashion and Retail Ltd9:16 pm IST

    ABFRL approves Q1 2026 unaudited standalone and consolidated results; amalgamation and ICRPL stake increase approved

    Financial results

    • Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved.
    • Comparatives restated for June 30, 2025 and March 31, 2026.

    Amalgamation and corporate actions

    • Scheme of amalgamation of Jaypore E-commerce Private Ltd and TG Apparel & Decor Private Limited approved by NCLT.
    • Amalgamation effective August 1, 2026; restatement in standalone results.
    • NCLT order dated July 2, 2026; ROC filing July 10, 2026; subsidiaries dissolved without winding up.
    • Rights issue of 3,65,19,197 equity shares aggregating to 175 crore; ICRPL stake to 89.29%.
    • Subscription completed on May 20, 2026.
    • ESOP allotment: 26,267 equity shares allotted on June 30, 2026.

    Auditor remarks and governance timing

    • Auditors' conclusions not modified despite amalgamation-related restatements.
    • Trading window closed for 48 hours post-announcement.
    Read the original filing
  5. Sportking India Ltd6:02 pm IST

    Sportking India Q1 FY27: strong revenue growth, margin uplift, Odisha expansion on track

    Financial Performance

    • Strong start to FY27 with revenue growth and profitability improvement.
    • Profitability aided by better yarn realizations, export demand, and disciplined raw-material procurement.
    • Input-cost management helped margins despite cotton prices rising.
    • No material contribution from cotton import duty to this quarter.

    Operating Update

    • Cotton yarn realizations improved; global yarn demand recovering.
    • Europe demand improving; UK–India FTA may aid exports later.
    • Export share around 50% of business; China became a larger buyer.
    • Export book maintained at 70–90 days; inventory cycle around 90 days.
    • Odisha greenfield project: 150,000 spindles; Phase 1 production in Q3 FY27.

    Projects and Capex

    • Odisha capex about INR1,000 crores (INR975 crores disclosed); Phase 1 adds 40% capacity.
    • Phase 1 commissioning in next quarter; full project complete within this financial year.
    • Phase 1 EBITDA uplift 300–400 bps versus existing plants.
    • Greenfield output to start contributing in Q4; ramp fully in FY28.
    • Solar project commenced commercial operations; annual savings around INR15 crores.
    • Power-cost savings 12–15% due to renewable energy share.

    Outlook and Guidance

    • FY27 revenue guidance around INR3,000 crores; FY28 around INR4,000 crores.
    • Utilization targeted at 96–97% by start of next financial year.
    • Odisha plant to lift margins; long-term margins stay higher than past levels.
    • Downstream acquisitions to contribute 8–10% topline from next year.
    • Merger via preferential issue; small cash outflow; debt-neutral.
    • US exports not direct; vendors' US lift rising.
    • Middle East demand did not meaningfully affect exports.
    • Odisha subsidies: 30% capex subsidy; INR2.5 per unit power subsidy.
    • Capex plan: INR1,000 crores for Odisha; completed by end of this year.

    Q&A Highlights

    • UK FTA incremental demand seen last month; no orders yet.
    • Odisha ramp-up: 5–6 months to full ramp; 90% utilization by March.
    • Cotton-price volatility; current quarter looks similar or better.
    • China became a buyer; Bangladesh steady; demand outlook supported by FTAs.
    • US tariffs post; not direct; vendor lift rising.
    • Downstream strategy to be shared in 6–8 months; 8–10% topline target.

    Risks and Watchpoints

    • Cotton import duty extension risk; government discussions ongoing.
    • Raw-material price volatility impact on spreads.
    • Execution risk on Odisha project capex and ramp.
    • Dependence on policy environment and FTAs.
    Read the original filing
  6. Amanta Healthcare Ltd10:16 pm IST

    Amanta Healthcare Q1 FY27: Revenue INR 69 cr; SteriPort ~44% of sales; Line 3 and SVP expansion on track

    Financial Performance

    • Q1 FY27 revenue INR 69 crores, up 5% YoY; EBITDA margin ~22%.
    • SteriPort accounts for about 44% of revenue; high-margin product mix supporting profitability.
    • QB: EBITDA INR 15 crores; EBITDA margin remained about 22%.

    Operational Update

    • SteriPort Line 3 commissioning shifted to Q2 FY27 due to civil delays.
    • Capacity rises from 6.6 crore to about 12 crore bottles annually.
    • SVP facility to commence operations in Q4 FY27; first inhalation product mid-September FY27.
    • FDA-approved plans; validation complete by Aug 18; commercial production by last week of August.

    Capex and Projects

    • SteriPort Line 3 capex ~ INR 90 crores; ~INR 80 crores spent so far.
    • SVP capex ~ INR 30 crores; ~INR 7 crores spent; remainder in coming quarters.
    • Solar power: 10.8 MW captive plant commissioned since June 2026; expected to cut power costs.

    Guidance and Outlook

    • Margin expansion target 4-5% including INR 9 crores solar savings.
    • FY27 baseline revenue around INR 370 crores; SteriPort contributes ~INR 70 crores over seven months.
    • FY28 peak revenue ~ INR 425 crores; EBITDA margins ~ 25-26%.
    • SteriPort Line 3 operational by Aug 24-25, 2026; SVP by March FY27.

    Balance Sheet and Cash Flow

    • Debt-to-equity at 1.06; annual debt reduction expected at INR 30-35 crores.
    • Interest expense trending down; FY27 ~ INR 21 crores; FY28 ~ INR 19 crores.

    Q&A Highlights

    • Line 3 annual top-line expected INR 120 crores; seven months contributed ~INR 70 crores.
    • Depreciation from new line ~ INR 4.5 crores annually; total incremental ~ INR 6 crores.
    • ROCE: SteriPort line ~16-17%; SVP ~14-15%.
    • FAT in USA scheduled for November; SVP pipeline includes 20 products; inhalation product commercialized mid-September FY27.
    • R&D: 5 scientists in F&D; 8-10 F&D and 3-4 regulatory staff for advanced markets.
    Read the original filing
  7. Aashka Hospitals Ltd11:46 pm IST

    Aashka Hospitals signs MOU for strategic restructuring to form single entity with 70% stake.

    Parties and purpose

    • Parties: Aashka Hospitals Limited and Rhythm Medical Stores; Rhythm Multispeciality Hospital.
    • Also party: Cardioplus Heart Care; Rhythm Medical & Heart Hospital.
    • Purpose: strategic arrangement to restructure into a single company with Aashka majority stake.

    Key terms

    • Aashka to hold 70% voting rights and capital in the newly emerged company.
    • Aashka to acquire 70% equity shares or voting rights from existing shareholders; price via valuation on transaction date.
    • Post-transaction, Aashka will control the majority of board and decisions.
    • Initial parties are not related to Aashka/promoter group.
    • Post-transaction, the newly emerged entity would be a related party to Aashka.
    • RPT status: not an RPT for this MOU; post-restructuring entity would be related party.
    • No shares issued at present; future issuance subject to valuation.
    • Duration not specified.

    Impact and governance

    • Ownership/control shift: 70% stake to Aashka; majority control.
    • Post-transaction consolidation creates a single entity managing Rhythm group units.
    • No financing terms disclosed.

    Other disclosures

    • Regulatory approvals not specified; filing references Annexure I.
    Read the original filing
  8. Delhivery Ltd11:01 pm IST

    Delhivery elevates Vani Venkatesh to Deputy CEO; Ajith Pai to depart September 2026

    Executive leadership appointments

    • Vani Venkatesh elevated to Deputy CEO, effective immediately.
    • Joined Delhivery February 2025 as Chief Business Officer and KMP.
    • Will lead Revenue, Marketing and Customer Experience with Operations coordination.

    Other governance changes

    • Ajith Pai to move on September 15, 2026 to pursue opportunities.
    • Pai's responsibilities to be transitioned to the new executive operations leadership.
    • Earlier 2026: Varun Bakshi named Chief Sales Officer; other COOs and CPO roles appointed.
    Read the original filing
  9. Apollo Micro Systems Ltd9:38 pm IST

    Apollo Micro Systems to acquire 41.33% Premier Explosives stake; Q1 FY27 revenue up 88.6% YoY

    Business overview

    • Pure-play defence electronics firm focused on indigenous missile programs and DRDO collaborations.
    • Aims to become a Global OEM across land, air, sea over the next decade.
    • Strategic emphasis on R&D, vertical integration, and targeted acquisitions.

    Operational highlights

    • SPA signed July 9, 2026 to acquire 41.33% stake in Premier Explosives Ltd (cash).
    • GOI license to manufacture weapons and ammunitions; MIGM and Limpet Mines entering production.
    • AoN for MIGM accorded by DcPP on 3 July 2026; production phase.
    • Make-II PSO for SAVIOR-ASW awarded by Indian Navy; production to follow.
    • Greenfield expansion to 12x capacity; INR 300 crore capex; 2.47 lakh sq ft land.
    • Export-first trajectory; converting first export order into sustained international revenue.
    • Best quarter in Q1FY27; standalone EBITDA margin 31.0%.

    Financial performance

    • Q1FY27 consolidated revenue from operations Rs 2,512.9 Mn; total revenue Rs 2,535.4 Mn; YoY growth 88.6%.
    • EBITDA (ex Other Income) Rs 537.3 Mn; EBITDA margin 21.4%.
    • PAT Rs 252.2 Mn; PAT margin 10.0%; standalone PAT Rs 278.3 Mn; margin 17.9%.
    • Consolidated borrowings Rs 5,432.6 Mn; cash Rs 1,561.1 Mn; total liabilities Rs 23,685.1 Mn.
    • Cash flow: FY26 operating cash flow -1,297.6 Mn; financing activities 5,358.9 Mn; net cash change 492.3 Mn.
    • Q1FY27 standalone revenue Rs 1,558.9 Mn; PAT Rs 278.3 Mn; EBITDA margin 31.0%.

    Capital structure & liquidity

    • Borrowings rose significantly to Rs 5,432.6 Mn by FY26; no external rating disclosed.
    • Strategic stake purchase increases equity mix; cash portion involved.
    • Liquidity remains positive with cash balance of Rs 1,561.1 Mn.

    Strategic priorities & outlook

    • Vision 2036: become a global OEM with revenues across land, air, sea.
    • Pursue inorganic growth via acquisitions to expand value chain.
    • Develop autonomous weapons and platforms; continue R&D in RF, AI, autonomy, INS.
    • Greenfield expansion supports scaling to 12x capacity; large capex and land bank.
    • Export growth to sustain international revenue stream.

    Risks

    • Industry features high entry barriers; reliance on DRDO programs and ToT; regulatory needs.
    • Regulatory/export controls; long development cycles; mitigated by in-house manufacturing and diversified portfolio.

    Governance & leadership

    • MD: Karunakar Reddy Baddam; WTD Operations: Addepalli Krishna Sai Kumar; WTD Technical: Chandrapati Venkata Siva Prasad.
    • MoUs with BEL, Munitions India, IIT Chennai, and Indian Navy; strategic collaborations.
    • Premier Explosives stake indicates a significant shareholder update.
    Read the original filing
  10. Affle 3I Ltd10:45 pm IST

    Affle reports Q1 FY2027 revenue up 20.4% to INR 747.2 crore; acquires AdColony assets

    Overview

    • Q1 FY2027 consolidated revenue of INR 747.2 crore, up 20.4% YoY.
    • EBITDA of INR 167.6 crore, up 20.0% YoY; EBITDA margin 22.4%.
    • PAT INR 128.4 crore, up 21.7% YoY; PBT INR 157.8 crore, up 22.1%.

    Key financials

    • Revenue: INR 747.2 crore; YoY growth 20.4%; QoQ growth 3.1%.
    • EBITDA: INR 167.6 crore; margin 22.4%.
    • PAT margin 16.6%; PAT INR 128.4 crore.

    Strategic developments

    • Acquired strategic AdColony assets in Q1 FY2027.
    • Strengthened AI-powered Consumer Platform stack for conversions across mobile, CTV and AICDs.
    • CPCU revenue INR 745.5 crore; 20.2% YoY; 12.4 crore converted users in Q1.

    Outlook and guidance

    • Management remains confident in delivering medium-term guidance.
    • Vision of 10x growth remains intact; geographic expansion continues.
    Read the original filing